Overview

Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of sarcosinamide nitrosourea in treating patients who have metastatic or unresectable solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide
Carmustine